BlackRock LifePath 2050 S
Park Avenue Plaza,55 East 52nd StreetNew York, NY 10055
Map
Phone: 877-224-1544
| Category: | Target Date 2050+ | | Fund Family: | BlackRock | | Net Assets: | 26.84M | | Year-to-Date Return: | -2.02% | | Yield: | 1.12% | | Morningstar Rating: | N/A | | Fund Inception Date: | 30-Jun-2008 |
|
Dagmar Nikles
Lead Manager since
01-Jul-2008 | | | Nikles is an employee of Barclays and BGI and is primarily responsible for the day-to-day management of the LifePath Funds. She has been a member of the asset allocation portfolio management team since July 2003. Prior to joining BGI, she received her Financial Risk Manager Certification and prior to that, she was an assistant portfolio manager and analyst at Zurich Scudder Investment from 2000 to 2002. |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | NaN | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | NaN | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks to maximize return consistent with the quantitatively measured risk that investors on average may be willing to accept given their investment time horizon.
The fund invests all of assets in a corresponding Master Portfolio which allocates and reallocates its assets among the Underlying funds. As of September 30, 2009, it held approximately 98% of assets in Underlying funds that invest primarily in equity securities, 2% of assets in Underlying funds that invest primarily in bonds and the remainder of assets in Underlying funds that invest primarily in money market instruments. |
| Last Dividend
(31-Dec-09):
| 0.09 | | Last Cap Gain
(31-Dec-09):
| 0.55 | | Annual Holdings Turnover
(18-Mar-10):
| .00% | | Average for Category:
| 37.90% |
|
| Expense | LPSGX | Category
Avg | | Total Expense Ratio: | 0.29%
| 0.62% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 5.22% | | Max Deferred Sales Load: | %
| 2.18% | | 3 Yr Expense Projection*: |
$ 160 | $125 | | 5 Yr Expense Projection*: |
$ N/A | $197 | | 10 Yr Expense Projection*: |
$ N/A | $355 |
|
|
0.35% Nasdaq 
Profile
